Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,16071,753,1.10 [0.95-1.26],0.1886254521461146
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,15495,237,1.12 [0.88-1.43],0.3665698285115009
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18121,149,1.33 [1.03-1.71],0.0276978752726794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,11287,850,1.06 [0.92-1.23],0.3852868749216005
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18082,110,1.23 [0.89-1.69],0.2044716425244186
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,16156,76,0.87 [0.52-1.46],0.6082830201615346
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19260,109,1.19 [0.86-1.63],0.2961851967794831
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19248,75,1.32 [0.94-1.85],0.1067700740704769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,15744,54,1.30 [0.86-1.97],0.2117950767614943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18361,107,0.85 [0.55-1.32],0.4664708916864257
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18323,69,0.92 [0.55-1.54],0.752683137308383
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19328,60,1.20 [0.79-1.83],0.3880135461751293
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19371,51,1.02 [0.59-1.76],0.940401669658956
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19369,49,1.06 [0.62-1.81],0.841648542588344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,18976,50,1.36 [0.91-2.02],0.1306338894647032
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18086,357,0.93 [0.74-1.17],0.5340097992887627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,17846,117,0.72 [0.45-1.15],0.1699245550323918
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,17987,258,0.97 [0.75-1.26],0.8250751498648676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",13994,82,1.26 [0.90-1.76],0.1706673985230223
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",13960,48,1.41 [0.96-2.07],0.0756408287926991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",14239,327,1.05 [0.86-1.29],0.6188094941689143
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",14247,335,1.06 [0.86-1.29],0.590486765983526
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",8042,315,0.82 [0.64-1.07],0.1399985849781324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6354,169,1.07 [0.81-1.42],0.6391370195841726
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",13958,46,1.17 [0.71-1.91],0.5405121534368393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,16616,601,1.20 [1.04-1.38],0.0149849867848125
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18085,385,0.91 [0.73-1.13],0.3818467514036375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,18900,133,0.93 [0.64-1.34],0.6957034536061345
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19406,122,0.88 [0.59-1.32],0.5446084472148233
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,19137,77,1.00 [0.64-1.57],0.9899594645469288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19411,77,0.79 [0.47-1.36],0.3985837985582273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Stomach,19459,55,0.86 [0.47-1.57],0.6183777539245072
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,19261,245,1.05 [0.82-1.34],0.7196250728577425
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19438,87,1.20 [0.84-1.71],0.3175865627772887
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19443,73,1.29 [0.90-1.84],0.163392967950136
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19370,49,0.89 [0.48-1.66],0.7160206233609625
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",19373,48,0.90 [0.48-1.67],0.7338529046224962
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,19320,125,1.24 [0.94-1.65],0.1340824969441009
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19439,56,0.86 [0.48-1.56],0.6271582005678112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,19335,147,1.19 [0.90-1.57],0.2254990308926769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of breast,10241,39,1.19 [0.70-2.01],0.5160358757693397
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,10113,258,0.93 [0.71-1.21],0.5882815553184859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18185,157,1.32 [1.03-1.68],0.0274079260319248
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,17755,265,1.30 [1.07-1.58],0.0075013791866211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,17755,265,1.30 [1.07-1.58],0.0075013791866211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),15680,436,1.08 [0.90-1.30],0.3926135178305984
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,18956,50,1.29 [0.85-1.98],0.2349205296379525
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19181,46,1.07 [0.62-1.85],0.7999675738389026
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,14135,1293,1.01 [0.90-1.14],0.8700716537526388
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18044,528,1.16 [0.99-1.35],0.0667543994580345
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17117,114,1.25 [0.92-1.71],0.151008425582708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18131,137,1.34 [1.03-1.74],0.0285934793846924
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17108,105,1.29 [0.95-1.77],0.1045923872307479
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17624,621,1.14 [0.97-1.33],0.1109304439507043
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17605,602,1.12 [0.96-1.32],0.1517580020450878
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,17944,143,1.14 [0.80-1.61],0.4702969743769963
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",17943,142,1.14 [0.80-1.61],0.4706537691356944
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,13987,1145,0.99 [0.87-1.12],0.8281692306800279
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",12983,141,0.81 [0.55-1.21],0.3060983161661305
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,13906,1064,0.98 [0.86-1.12],0.8185994936375469
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,12884,42,0.92 [0.47-1.78],0.7973353920107883
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",12912,70,1.22 [0.82-1.82],0.3280378590201499
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,16012,427,1.10 [0.92-1.32],0.2854863135407306
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",15718,133,0.76 [0.49-1.16],0.1958817770751331
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19152,92,0.68 [0.40-1.16],0.1573403583624394
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19201,67,0.55 [0.28-1.08],0.0837695722593485
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18172,30,0.73 [0.29-1.81],0.4942074460650845
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19392,30,0.74 [0.30-1.82],0.5095175731266044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",15615,30,0.74 [0.30-1.83],0.5170201428843787
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Alcohol dependence,18178,36,0.50 [0.20-1.29],0.1531641392671804
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,18128,43,0.93 [0.48-1.84],0.8442009560526356
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15613,28,1.56 [0.97-2.50],0.0682353929710031
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",15785,200,1.10 [0.85-1.43],0.4693428433411477
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression,18285,180,1.13 [0.87-1.47],0.3731223770359665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression or dysthymia,15511,156,1.02 [0.74-1.40],0.9096741693183832
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",15672,87,1.39 [1.03-1.87],0.0298400036299289
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Other anxiety disorders,18280,53,1.19 [0.76-1.86],0.4526998134829563
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,16040,1225,1.10 [0.99-1.23],0.0869252972121292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14089,84,1.05 [0.70-1.57],0.8306960600335603
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19386,63,1.01 [0.62-1.65],0.9582654550906374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18390,374,1.07 [0.88-1.31],0.478086624728778
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,18117,101,0.88 [0.57-1.36],0.5681325118670345
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,18064,48,0.82 [0.42-1.60],0.5640884922073456
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19267,43,0.90 [0.46-1.73],0.7428818919876943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18515,95,1.46 [1.12-1.90],0.0045746134265514
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,18145,129,0.93 [0.64-1.34],0.6814425119852088
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,19037,98,0.93 [0.61-1.42],0.7482708175806114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18473,585,1.04 [0.88-1.22],0.6581414729533053
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",17974,86,0.81 [0.49-1.34],0.4158704175212548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18245,357,1.06 [0.87-1.30],0.5635053046951849
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19162,64,0.77 [0.42-1.39],0.381765195351005
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,19146,48,nan [nan-nan],
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,19007,95,1.39 [1.04-1.85],0.0245809228724148
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",18748,355,1.23 [1.03-1.46],0.0210965865755608
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18607,214,1.24 [1.00-1.55],0.0521304636756315
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18445,52,1.25 [0.81-1.94],0.3184985125765909
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18504,111,1.07 [0.75-1.53],0.7161413479056467
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18478,85,1.09 [0.73-1.63],0.6663123990718103
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,14944,209,1.05 [0.80-1.37],0.7416347792463025
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,15251,516,0.89 [0.73-1.08],0.2433431054805749
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,18298,237,0.86 [0.64-1.15],0.3104077725637227
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19105,51,1.12 [0.68-1.86],0.6599234939143985
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2155,51,1.09 [0.63-1.86],0.7598610290711486
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17001,51,1.16 [0.69-1.94],0.5773256996851035
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,18630,114,0.87 [0.58-1.32],0.5239685207225386
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,18575,59,1.01 [0.60-1.68],0.9832520733309058
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",18694,58,0.92 [0.52-1.61],0.7669747545655413
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,18901,81,1.02 [0.66-1.57],0.9377621116031528
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19384,111,0.78 [0.49-1.22],0.2703222535761987
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,18495,96,0.99 [0.65-1.48],0.9447803932803548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,12004,3702,1.01 [0.92-1.09],0.8909910040274849
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,18688,80,0.89 [0.54-1.45],0.6318688794692888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",12767,2574,1.03 [0.94-1.13],0.5108744742634277
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,12791,2598,1.03 [0.94-1.13],0.5778479710388965
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10253,60,0.66 [0.34-1.29],0.2256183329009582
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17089,1465,1.05 [0.94-1.17],0.3654604814869736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,16497,873,1.18 [1.04-1.33],0.0109528250589247
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18317,270,1.13 [0.91-1.41],0.2737115022834655
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18600,553,1.01 [0.85-1.20],0.9253154076059464
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19321,111,0.57 [0.34-0.96],0.0351901175945417
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",15973,349,0.93 [0.74-1.17],0.5520704391069795
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,16775,1171,1.05 [0.93-1.18],0.4132453044088814
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18497,113,1.05 [0.73-1.52],0.7807993182735387
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,18696,237,1.23 [0.99-1.53],0.0558737139758888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18490,106,1.10 [0.77-1.57],0.5933949712995279
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18491,107,1.10 [0.78-1.57],0.5815180075263766
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10295,102,1.12 [0.78-1.61],0.5500919681149821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14462,61,1.43 [0.98-2.07],0.0614993131225171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,14538,137,1.04 [0.74-1.46],0.8342584061954413
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7738,111,1.04 [0.71-1.51],0.8482524011426472
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,8188,561,1.01 [0.85-1.21],0.8932573847846939
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,14479,78,0.91 [0.55-1.49],0.7066968832422098
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,14509,108,0.96 [0.64-1.44],0.8400236498641871
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18134,238,0.98 [0.75-1.28],0.8866794401258499
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",18427,156,0.86 [0.60-1.23],0.4067872022603177
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",18455,140,0.81 [0.55-1.20],0.3032043758163852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",18542,122,0.83 [0.55-1.26],0.3827304125341355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18106,83,1.08 [0.71-1.64],0.7244776722968779
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18169,146,1.32 [1.02-1.70],0.0320012949417868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18046,140,1.28 [0.99-1.66],0.0636778327285079
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18024,118,1.14 [0.82-1.58],0.4375951266528592
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19219,113,1.15 [0.82-1.60],0.4132903744876136
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,18336,430,0.88 [0.71-1.09],0.2435177577404779
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,18136,93,1.11 [0.77-1.61],0.5747640888651726
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,14414,1806,0.97 [0.88-1.08],0.5701344128899439
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19329,71,1.18 [0.79-1.76],0.4113766268391253
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,17416,224,1.00 [0.76-1.32],0.9848322241385916
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",17390,198,0.91 [0.67-1.24],0.5610099697802472
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,18438,242,1.07 [0.84-1.36],0.5809995834097835
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,18432,236,1.09 [0.86-1.39],0.4680646689418287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,18845,463,0.80 [0.65-1.00],0.0488156618208018
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,18459,77,0.87 [0.52-1.44],0.5804137095122142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,18498,116,0.75 [0.48-1.17],0.2062365114917789
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18672,290,0.72 [0.54-0.97],0.0288555158320826
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,18498,116,0.62 [0.38-1.01],0.0566475435519286
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6262,63,1.04 [0.63-1.72],0.8816694886406933
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,16822,942,1.02 [0.89-1.16],0.7640413000043408
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,18088,205,1.00 [0.75-1.33],0.9843112323731869
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18128,245,0.97 [0.74-1.26],0.7998313569111142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18128,245,0.97 [0.74-1.26],0.7998313569111142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18017,713,0.97 [0.83-1.13],0.6893919226518992
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Asthma,12725,713,0.97 [0.83-1.14],0.6978137265504163
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",12412,713,0.97 [0.83-1.14],0.6938275259920292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",12718,706,0.98 [0.83-1.14],0.7599346199254055
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,18975,119,1.45 [1.13-1.86],0.0035609907618504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,18062,93,1.47 [1.13-1.92],0.0043105796301407
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19053,93,1.48 [1.13-1.93],0.0043057778256804
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18055,86,1.39 [1.03-1.87],0.0311950373798348
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,17137,115,1.08 [0.77-1.54],0.6487975697952117
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,17265,243,1.12 [0.89-1.41],0.34049695026386
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18063,114,1.15 [0.83-1.61],0.4001540099523627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,12570,5338,1.00 [0.93-1.08],0.8938278445893223
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19081,286,0.89 [0.68-1.15],0.3679492554801731
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19460,31,0.38 [0.13-1.12],0.0789679418094023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,19461,29,0.36 [0.12-1.11],0.0761725000146997
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,18880,85,1.09 [0.73-1.62],0.687075307309514
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18868,73,0.89 [0.54-1.48],0.6582157284916998
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19456,34,0.47 [0.18-1.26],0.1329936955451159
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18875,80,0.84 [0.50-1.39],0.4912641758451573
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18649,78,1.14 [0.77-1.70],0.5031765204588949
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19366,51,1.26 [0.82-1.96],0.2942086174635231
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,13810,273,0.76 [0.56-1.02],0.0675841835729657
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",15655,2118,1.01 [0.92-1.11],0.7719944829079902
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,13875,338,0.92 [0.73-1.16],0.4655911682350122
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,14233,696,1.10 [0.95-1.26],0.2080213121513038
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,13606,69,0.89 [0.52-1.50],0.6538124824132256
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13770,233,1.05 [0.81-1.35],0.716901983012647
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13609,72,0.61 [0.32-1.15],0.125664970211124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,13695,158,0.81 [0.56-1.18],0.2724454080439565
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,13659,122,0.85 [0.57-1.29],0.4499654758670979
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19319,86,0.83 [0.50-1.36],0.4518043417405473
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,13652,115,0.82 [0.53-1.27],0.3674296652629643
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),14345,808,0.94 [0.81-1.10],0.437918044192252
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,19344,78,0.87 [0.53-1.44],0.5879298481936042
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,13935,398,0.95 [0.77-1.17],0.6458891480965995
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,13723,186,0.95 [0.70-1.29],0.746856668802961
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19339,102,1.20 [0.86-1.66],0.2838266151859964
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,19333,67,0.93 [0.56-1.55],0.7780521093503977
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,16450,1708,1.04 [0.94-1.15],0.3950470049716986
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,15415,673,0.94 [0.80-1.11],0.478327882764316
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,14846,104,0.90 [0.58-1.39],0.6294075212055569
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,14830,88,1.20 [0.83-1.73],0.3361942630667739
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15665,923,1.10 [0.96-1.24],0.1613262973761994
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18564,640,0.94 [0.79-1.11],0.4529756792892867
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,14336,1934,1.01 [0.92-1.12],0.7952933995798763
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19173,41,0.41 [0.16-1.03],0.0589948514783537
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19412,51,0.41 [0.18-0.94],0.0346004906533597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,17975,51,0.41 [0.18-0.94],0.0347308695524325
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,17961,37,0.38 [0.14-1.01],0.0532772375699769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19345,120,0.78 [0.51-1.20],0.2609659870189225
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,18044,120,0.78 [0.51-1.20],0.2625548672578898
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18035,111,0.74 [0.46-1.17],0.1980950593018298
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18449,525,1.00 [0.84-1.20],0.9753930912975706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18441,517,1.01 [0.85-1.21],0.892199114943939
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12512,110,1.11 [0.79-1.56],0.534787447861943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal stricture,18967,110,1.12 [0.79-1.57],0.5288847681841933
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12472,70,0.93 [0.56-1.54],0.7778945552307409
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,13142,740,0.92 [0.78-1.08],0.3043942999417783
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12536,134,0.93 [0.64-1.34],0.6878531739064766
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,12663,261,1.10 [0.87-1.38],0.4215745184350971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,17760,238,1.07 [0.84-1.36],0.5766671306846594
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19065,77,0.86 [0.52-1.43],0.5677191882403823
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12493,91,1.28 [0.92-1.79],0.148480941203772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12445,43,1.24 [0.75-2.05],0.4071727840636749
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13204,802,0.98 [0.85-1.14],0.8038012951360396
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,12713,311,0.97 [0.76-1.23],0.7771540265750596
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19052,64,0.82 [0.46-1.46],0.5025902825058849
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,18698,98,1.27 [0.93-1.74],0.1372572317433412
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,18652,52,1.56 [1.12-2.17],0.0085053573879637
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18212,588,0.96 [0.81-1.14],0.6692006831999646
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,18096,472,0.95 [0.79-1.16],0.6358006763954278
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,17728,104,0.85 [0.55-1.32],0.4597477765581499
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17666,42,1.14 [0.67-1.95],0.6296313335540806
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,17685,61,1.19 [0.79-1.82],0.4068928775351186
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19303,61,1.20 [0.79-1.83],0.3871678784100922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18205,274,1.28 [1.06-1.56],0.0113207074854617
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,17987,56,1.67 [1.23-2.26],0.0010603026109053
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,17979,48,1.79 [1.33-2.41],0.0001300654054797
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",17976,45,1.19 [0.72-1.97],0.4883856249946002
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18109,178,1.11 [0.84-1.47],0.4525933819918514
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,18102,171,1.13 [0.86-1.49],0.3803552445296672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,16397,1352,1.02 [0.91-1.14],0.7062637873272775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19021,94,1.21 [0.86-1.71],0.270990447363273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19110,370,1.04 [0.86-1.28],0.6658861018198021
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,17766,519,0.98 [0.81-1.17],0.7922734428594114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,18595,321,1.04 [0.83-1.30],0.7450398789564171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18332,58,0.95 [0.54-1.66],0.8569414483994093
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18502,228,0.95 [0.71-1.26],0.7229815454723872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19194,81,0.74 [0.43-1.28],0.2771429145362322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19171,58,0.89 [0.50-1.58],0.687913235615141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19161,48,0.96 [0.53-1.75],0.8929176566280806
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19111,63,1.22 [0.81-1.84],0.3421786054849206
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19110,62,1.23 [0.82-1.85],0.3182738232729152
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18784,44,1.19 [0.72-1.97],0.5041987354950871
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19047,307,0.98 [0.78-1.24],0.863897601540584
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17345,98,0.74 [0.45-1.21],0.2290749215213176
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17331,84,1.13 [0.77-1.67],0.5350327206058146
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17305,58,1.10 [0.68-1.77],0.7009920173366783
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17438,191,0.97 [0.72-1.31],0.8326693592334998
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17425,178,0.92 [0.67-1.27],0.6178035349187869
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,12754,3693,1.05 [0.97-1.13],0.2145688507701595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,14101,2295,1.05 [0.96-1.15],0.2425654945070071
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,17280,1101,0.95 [0.84-1.08],0.4551893641627543
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,11956,150,1.33 [1.05-1.69],0.0186137411774775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,12270,464,1.06 [0.88-1.26],0.5495099455729576
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19027,144,1.37 [1.08-1.74],0.0095219655302416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19031,132,1.40 [1.10-1.78],0.0059913805045764
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,13160,1354,1.04 [0.93-1.17],0.4988402953179385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",15281,1354,1.02 [0.91-1.15],0.6746404981189247
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,11881,75,1.15 [0.76-1.73],0.5111735746796636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",18844,72,1.13 [0.75-1.72],0.5605298784407571
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,12032,226,0.81 [0.58-1.11],0.1839681443836142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,11902,96,1.15 [0.80-1.65],0.4583501686611393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,12182,376,1.15 [0.96-1.38],0.1352596398167738
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19270,189,1.00 [0.75-1.34],0.9938690642057914
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,12402,596,0.95 [0.79-1.14],0.572069503811287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,12262,456,0.95 [0.78-1.16],0.636435021635808
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,12925,1119,1.04 [0.92-1.18],0.5212019390872739
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11891,85,1.13 [0.77-1.66],0.5219473881536572
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12048,242,1.19 [0.96-1.48],0.1084740736882614
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11871,65,1.33 [0.92-1.93],0.1227336610583922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11882,76,1.28 [0.90-1.81],0.175895176407022
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12177,371,1.09 [0.89-1.33],0.3921803521446141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12139,333,1.11 [0.91-1.36],0.3065885339612412
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,14671,230,0.89 [0.66-1.19],0.4213109620320069
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18837,101,1.40 [1.06-1.84],0.0185996563472017
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,18797,61,1.12 [0.70-1.77],0.6388307954375438
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16178,67,0.64 [0.33-1.21],0.1706033447093066
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,16427,316,0.90 [0.70-1.16],0.4103916406904662
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,16900,789,0.94 [0.80-1.09],0.4046247427599808
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,16316,205,0.85 [0.62-1.17],0.3208959567879539
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16208,97,0.91 [0.58-1.41],0.661389310836719
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",16698,587,0.96 [0.81-1.15],0.6816226741183599
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16148,37,0.91 [0.45-1.85],0.8001928975284935
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16291,180,0.93 [0.67-1.27],0.6350873323923443
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16183,72,1.00 [0.62-1.59],0.990993215740006
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16180,69,0.99 [0.61-1.61],0.9760058721026068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16219,108,0.70 [0.43-1.14],0.1486664833359538
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16161,50,1.34 [0.88-2.04],0.1731850602576788
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16356,245,0.98 [0.75-1.27],0.8636748219832898
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16466,287,0.91 [0.70-1.18],0.4697952549391972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16248,69,0.86 [0.50-1.48],0.5908054626182578
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16286,107,1.00 [0.67-1.48],0.9899624527212768
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16249,70,1.14 [0.75-1.74],0.5330789916490035
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16216,37,1.67 [1.18-2.38],0.0041112383744519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16319,140,0.93 [0.66-1.33],0.7088951590199359
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16312,133,1.01 [0.72-1.42],0.9659960868560448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16426,247,1.05 [0.82-1.35],0.6887434329585094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16229,50,1.35 [0.89-2.05],0.165001170139884
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16262,83,0.84 [0.51-1.40],0.5018118183760765
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16294,115,0.98 [0.67-1.43],0.9043877817409413
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16222,43,0.66 [0.30-1.45],0.2957279744326434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",16567,388,0.83 [0.66-1.06],0.1327698980049169
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16339,160,0.87 [0.61-1.24],0.4266169233960648
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16399,220,0.79 [0.57-1.09],0.1469686213825255
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,17498,202,1.14 [0.89-1.46],0.2925935054339662
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,17653,357,1.12 [0.92-1.35],0.2511653777686252
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17328,32,1.05 [0.54-2.06],0.8798856242720225
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17334,38,1.23 [0.72-2.08],0.4469476095827973
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17364,68,1.19 [0.80-1.79],0.3856164640857603
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,14307,3391,1.03 [0.95-1.11],0.4487046577890934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,7452,705,1.00 [0.85-1.18],0.992732831288901
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,16545,200,0.94 [0.69-1.27],0.679823867073633
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16406,61,0.79 [0.43-1.45],0.4449809514498702
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,16627,41,1.47 [0.93-2.33],0.0966428789287833
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,16634,48,1.19 [0.71-1.98],0.5042920830950979
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16639,53,0.78 [0.40-1.52],0.4578732842532859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19142,197,1.00 [0.76-1.33],0.982137209411115
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,18994,61,0.70 [0.36-1.33],0.2741538040563434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19093,148,1.08 [0.79-1.46],0.6407057065497241
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19003,58,1.03 [0.62-1.72],0.9030953756114146
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,17103,1002,1.04 [0.92-1.18],0.5129389744366176
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,16184,83,0.90 [0.56-1.44],0.6526429399573559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16178,77,0.98 [0.62-1.55],0.9199015287719178
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16396,295,0.93 [0.73-1.19],0.5524049628045613
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16214,113,1.25 [0.92-1.69],0.1536248463518459
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,16727,626,0.98 [0.83-1.16],0.8104236955621836
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,7150,403,0.87 [0.69-1.09],0.232583424097543
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6803,56,0.95 [0.54-1.68],0.8662479010101312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,6799,52,1.23 [0.77-1.98],0.3878064900371946
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6807,60,1.12 [0.68-1.85],0.6427560503316433
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6822,75,1.16 [0.76-1.76],0.4864252556759755
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6838,91,1.24 [0.88-1.76],0.2163940758382123
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10153,200,0.94 [0.70-1.26],0.6742112163431886
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10017,64,0.91 [0.53-1.56],0.736007774967073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,10022,69,1.13 [0.74-1.72],0.5736672317141025
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10009,56,0.81 [0.44-1.49],0.4985525977861712
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10127,146,1.22 [0.93-1.60],0.1588323103307466
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,10025,44,1.48 [1.00-2.20],0.0497595211891901
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10027,46,1.39 [0.91-2.11],0.1229703948852131
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,9397,1552,1.00 [0.89-1.11],0.9596656102873768
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,7896,51,1.32 [0.87-2.00],0.1983593590839916
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7884,39,nan [nan-nan],
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8263,418,1.11 [0.93-1.33],0.2601438734934405
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7924,79,0.90 [0.56-1.45],0.6567637367855634
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8248,403,0.91 [0.73-1.13],0.404010988278022
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7970,125,1.01 [0.71-1.43],0.968358020211426
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8036,191,0.89 [0.64-1.22],0.4508900346997545
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,7859,14,0.37 [0.07-1.87],0.2291262535163251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,7884,39,1.16 [0.66-2.02],0.6097511531964246
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",10251,53,1.12 [0.69-1.83],0.6461732848264725
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,10253,48,1.00 [0.57-1.77],0.9878452228637808
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,10257,22,1.09 [0.52-2.30],0.8159126830572516
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",10255,26,1.29 [0.72-2.30],0.3985192988666319
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7910,65,1.13 [0.73-1.76],0.5819675198932617
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7895,50,0.73 [0.37-1.46],0.3803579200513128
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7906,61,0.99 [0.60-1.64],0.9749209172398008
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Irregular menses,10256,75,1.12 [0.75-1.70],0.5742138766877245
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",8014,169,0.88 [0.62-1.23],0.4449138146037892
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Menorrhagia,7925,80,0.60 [0.33-1.10],0.1007620392554534
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",10258,34,1.08 [0.57-2.06],0.8141963839943682
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7940,95,0.71 [0.43-1.18],0.1889972529527213
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7887,42,0.62 [0.28-1.40],0.2523557878417619
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8395,550,1.04 [0.88-1.23],0.6376662271910154
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19015,71,0.99 [0.62-1.60],0.979032971515078
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,16694,548,0.92 [0.77-1.11],0.3988330434867253
